Clinical Trial Update: Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sitagliptin to a sulphonylurea for people with type 2 diabetes during Ramadan has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• Sulphonylurea (class) (sulphonylurea class)

Snippet

Sponsor: University of Manchester | Conditions: Diabetes, Hypoglycemia | Phase 4 | Status: TERMINATED